Filtered By:
Infectious Disease: Genital Herpes
Drug: Estradiol
This page shows you your search results in order of date.
Order by Relevance | Date
Total 7 results found since Jan 2013.
Depo Medroxyprogesterone (DMPA) Promotes Papillomavirus Infections but Does Not Accelerate Disease Progression in the Anogenital Tract of a Mouse Model
Viruses. 2022 May 6;14(5):980. doi: 10.3390/v14050980.ABSTRACTContraceptives such as Depo-medroxyprogesterone (DMPA) are used by an estimated 34 million women worldwide. DMPA has been associated with increased risk of several viral infections including Herpes simplex virus-2 (HSV-2) and Human immunodeficiency virus (HIV). In the current study, we used the mouse papillomavirus (MmuPV1) anogenital infection model to test two hypotheses: (1) contraceptives such as DMPA increase the susceptibility of the anogenital tract to viral infection and (2) long-term contraceptive administration induces more advanced disease at the anog...
Source: Cancer Control - May 28, 2022 Category: Cancer & Oncology Authors: Jiafen Hu Sarah A Brendle Jingwei J Li Vonn Walter Nancy M Cladel Timothy Cooper Debra A Shearer Karla K Balogh Neil D Christensen Source Type: research
